IgG-TAA score was significantly higher in HER2-positive tumors as compared to HER2- negative cancers [mean fold change (FC) = 1.81; P = 0.032] and showed a tendency to be increased in estrogen receptor (ER) and progesterone receptor (PR) negative cancers (Figure 2A). The gene discussed is ESR1; the disease is cancer.